Novel menin inhibitors show promise for patients with advanced acute myeloid leukemias
Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias ...
Dec 11, 2023
0
0